IBRANCE

PALBOCICLIB · Pfizer Laboratories Div Pfizer Inc

Drug timelines are a Plus or Pro feature.

82 regulatory and trial events tracked for IBRANCE, covering 2014-06-30 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial [Phase 2]